Canada markets open in 7 hours 54 minutes

AVITA Medical, Inc. (RCEL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.75+0.03 (+0.34%)
At close: 04:00PM EDT
8.75 0.00 (0.00%)
After hours: 07:54PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 225.75M
Enterprise Value 179.10M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.42
Price/Book (mrq)4.60
Enterprise Value/Revenue 3.57
Enterprise Value/EBITDA -5.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.29
52-Week Change 3-45.60%
S&P500 52-Week Change 322.38%
52 Week High 321.70
52 Week Low 38.01
50-Day Moving Average 314.03
200-Day Moving Average 314.23

Share Statistics

Avg Vol (3 month) 3242.07k
Avg Vol (10 day) 3254.37k
Shares Outstanding 525.8M
Implied Shares Outstanding 625.8M
Float 824.81M
% Held by Insiders 10.66%
% Held by Institutions 128.16%
Shares Short (Apr 15, 2024) 41.18M
Short Ratio (Apr 15, 2024) 43.97
Short % of Float (Apr 15, 2024) 44.61%
Short % of Shares Outstanding (Apr 15, 2024) 44.59%
Shares Short (prior month Mar 15, 2024) 4590.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Jun 30, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -70.56%
Operating Margin (ttm)-86.46%

Management Effectiveness

Return on Assets (ttm)-25.35%
Return on Equity (ttm)-52.89%

Income Statement

Revenue (ttm)50.14M
Revenue Per Share (ttm)1.98
Quarterly Revenue Growth (yoy)50.10%
Gross Profit (ttm)N/A
EBITDA -41.94M
Net Income Avi to Common (ttm)-35.38M
Diluted EPS (ttm)-1.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)89.06M
Total Cash Per Share (mrq)3.46
Total Debt (mrq)42.41M
Total Debt/Equity (mrq)86.45%
Current Ratio (mrq)7.88
Book Value Per Share (mrq)1.91

Cash Flow Statement

Operating Cash Flow (ttm)-38.01M
Levered Free Cash Flow (ttm)-24.02M